Implants for spondylodesis (global market)
Spondylodesis is a surgical operation aimed at correcting the vertebral column. During this operation, two or (less commonly) three adjacent vertebrae are connected to each other using screws, rods and a bone implant. This method is used in the treatment of any spinal injuries and curvatures, in particular scoliosis, degeneration of intervertebral discs, hernia of intervertebral discs and spinal pathology due to tumor or infection.
2015: Volume of $5.9 billion
In 2015, the market for spondylodesis devices amounted to $5.867 billion, according to the data of the analytical company Allied Market Research.
The dynamics regarding 2014 are not given in the message. At the same time, it is predicted that by 2022 the market under consideration will grow by 3.4% per year and reach $7.435 billion by the end of this period.
In 2015, most of the sales of implants used as a vertebral column corrector came from North America. Analysts expect the leadership of the region in subsequent years.
Approximately 40% of the European market for spondylodesis devices in 2015 was occupied France by and. Germany The Asia-Pacific region is expected to have the highest growth rate (4.6 per cent per annum) due to improved infrastructure health care and increased health costs in developing countries such as and. India China
As for segments from a technological point of view, the lion's share was made up of solutions for thoracolumbal spondylodesis.
The largest manufacturers of tools for spondylodesis, analysts Allied Market Research name the following companies (listed alphabetically):
- Alphatec Holdings;
- B. Braun Melsungen;
- Depuy Synthes ( Johnson & Johnson );
- Exactech;
- Globus Medical;
- Medtronic;
- NuVasive;
- Orthofix International;
- Stryker Corporation;
- Zimmer Biomet Holdings.[1]